These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36538947)

  • 1. Risk of rebound psoriasis flare from systemic corticosteroid use in patients with psoriasis: A retrospective cohort study.
    Kresch M; Weingarten M; Guenin S; Wei N; Elbogen E; Correa da Rosa J; Lebwohl M
    J Am Acad Dermatol; 2023 May; 88(5):1182-1183. PubMed ID: 36538947
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on "Risk of rebound psoriasis flare from systemic corticosteroid use in patients with psoriasis: A retrospective cohort study".
    Long V; Choi E
    J Am Acad Dermatol; 2023 Apr; 88(4):e173-e174. PubMed ID: 36739901
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to comment on the article entitled "Risk of rebound psoriasis flare from systemic corticosteroid use in patients with psoriasis: A retrospective cohort study".
    Kresch-Vatch M; Lebwohl M
    J Am Acad Dermatol; 2023 Nov; 89(5):e215. PubMed ID: 36780949
    [No Abstract]   [Full Text] [Related]  

  • 4. [The unsuitability of using corticosteroid preparations in the treatment of psoriasis in children].
    Grishko TN
    Vestn Dermatol Venerol; 1989; (9):69-71. PubMed ID: 2532822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are Systemic Corticosteroids Causing Psoriasis Flare-Ups? Questionnaire for Danish Dermatologists, Gastroenterologists and Rheumatologists.
    Schwarz CW; Loft N; Andersen V; Juul L; Zachariae C; Skov L
    Dermatology; 2021; 237(4):588-594. PubMed ID: 33049749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoriasis Flares Following Systemic Glucocorticoid Exposure in Patients With a History of Psoriasis.
    Gregoire ARF; DeRuyter BK; Stratman EJ
    JAMA Dermatol; 2021 Feb; 157(2):198-201. PubMed ID: 33206132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful management of infliximab-induced generalized pustular psoriasis without therapy discontinuation in a patient with psoriatic arthritis.
    Zheng J; Gao Y; Ding Y
    Dermatol Ther; 2019 Nov; 32(6):e13132. PubMed ID: 31631466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic steroids in the treatment of psoriasis: what is fact, what is fiction?
    Mrowietz U; Domm S
    J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):1022-5. PubMed ID: 22830601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of treated anxiety and treated depression among patients with psoriasis and psoriatic arthritis treated with apremilast compared to biologics, DMARDs and corticosteroids: a cohort study in the United States MarketScan database.
    Vasilakis-Scaramozza C; Persson R; Hagberg KW; Jick S
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1755-1763. PubMed ID: 31981426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52-week, open-label, phase 3 study (UNCOVER-J).
    Saeki H; Nakagawa H; Nakajo K; Ishii T; Morisaki Y; Aoki T; Cameron GS; Osuntokun OO;
    J Dermatol; 2017 Apr; 44(4):355-362. PubMed ID: 27726163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy and safety of ixekizumab in Japanese patients with erythrodermic or generalized pustular psoriasis: subgroup analyses of an open-label, phase 3 study (UNCOVER-J).
    Okubo Y; Mabuchi T; Iwatsuki K; Elmaraghy H; Torisu-Itakura H; Morisaki Y; Nakajo K
    J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):325-332. PubMed ID: 30317671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A patient with psoriatic arthritis due to generalized pustular psoriasis (von Zumbusch type)].
    Seki K; Amano T; Nakayama Y
    Ryumachi; 1997 Aug; 37(4):568-73. PubMed ID: 9311283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of information in current guidelines regarding systemic corticosteroids in inflammatory diseases.
    Semble AL; Davis SA; Feldman SR
    Dermatol Online J; 2014 Mar; 20(3):. PubMed ID: 24656275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte kinetics in pustular psoriasis.
    Sauder DN; Steck WD; Bailin PB; Krakauer RS
    J Am Acad Dermatol; 1981 Apr; 4(4):458-60. PubMed ID: 7229149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of Patients with Generalized Pustular Psoriasis and Psoriatic Arthritis: A Retrospective Cohort Study.
    Manome-Zenke Y; Ohara Y; Fukui S; Kobayashi D; Sugiura K; Ikeda S; Arai S
    Acta Derm Venereol; 2022 Apr; 102():adv00685. PubMed ID: 35312017
    [No Abstract]   [Full Text] [Related]  

  • 16. Strategies to optimize efficacy, duration of remission, and safety in the treatment of plaque psoriasis by using tazarotene in combination with a corticosteroid.
    Lebwohl M
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S43-6. PubMed ID: 10898829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between traditional systemic antipsoriatic drugs and tuberculosis risk in patients with psoriasis with or without psoriatic arthritis: results of a nationwide cohort study from Taiwan.
    Chen YJ; Wu CY; Shen JL; Chen TT; Chang YT
    J Am Acad Dermatol; 2013 Jul; 69(1):25-33. PubMed ID: 23375515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive Aspergillus infection of middle ear in a patient treated with secukinumab, methotrexate, and corticosteroids for psoriasis and psoriatic arthritis.
    Rob F; Školoudík L; Chrobok V; Dědková J; Kašparová P; Podrazilová L
    J Dermatolog Treat; 2022 Nov; 33(7):3063-3065. PubMed ID: 35856655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generalized pustular psoriasis (von Zumbusch) following iatrogenic hypocortisolism.
    Augey F; Dissard C; Normand I; Daumont M
    Eur J Dermatol; 2004; 14(6):415-7. PubMed ID: 15564207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between metabolic syndrome and carotid intima-media thickness: cross-sectional comparison between psoriasis and psoriatic arthritis.
    Lin YC; Dalal D; Churton S; Brennan DM; Korman NJ; Kim ES; Husni ME
    Arthritis Care Res (Hoboken); 2014 Jan; 66(1):97-103. PubMed ID: 23983044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.